Abolfazl Avan

12.8k total citations · 1 hit paper
40 papers, 1.4k citations indexed

About

Abolfazl Avan is a scholar working on Psychiatry and Mental health, Physiology and Oncology. According to data from OpenAlex, Abolfazl Avan has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 9 papers in Physiology and 8 papers in Oncology. Recurrent topics in Abolfazl Avan's work include Dementia and Cognitive Impairment Research (15 papers), Health disparities and outcomes (5 papers) and Acute Ischemic Stroke Management (5 papers). Abolfazl Avan is often cited by papers focused on Dementia and Cognitive Impairment Research (15 papers), Health disparities and outcomes (5 papers) and Acute Ischemic Stroke Management (5 papers). Abolfazl Avan collaborates with scholars based in Canada, Iran and Netherlands. Abolfazl Avan's co-authors include Vladimir Hachinski, Elisa Giovannetti, Godefridus J. Peters, Saverio Stranges, Naghmeh Mokhber, Mario Di Napoli, Mahmoud Reza Azarpazhooh, Amin Amiri, Amir Avan and Mahmoud Reza Azarpazhooh and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Abolfazl Avan

36 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017

2019 322 citations Abolfazl Avan, Hadi Digaleh et al. BMC Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abolfazl Avan Canada	18	293	276	258	198	172	40	1.4k
Liming Dong China	23	296 1.0×	650 2.4×	267 1.0×	80 0.4×	65 0.4×	98	2.6k
Yuqing Zhang China	26	453 1.5×	452 1.6×	224 0.9×	134 0.7×	349 2.0×	112	2.6k
Yi Ren China	17	187 0.6×	195 0.7×	350 1.4×	68 0.3×	134 0.8×	70	1.4k
Tingting Yang China	24	173 0.6×	522 1.9×	207 0.8×	95 0.5×	150 0.9×	82	1.5k
Tan Xu China	27	111 0.4×	418 1.5×	751 2.9×	138 0.7×	224 1.3×	190	2.5k
Jin Zhou China	25	456 1.6×	606 2.2×	102 0.4×	89 0.4×	284 1.7×	97	1.8k
Antonino Catalano Italy	25	390 1.3×	472 1.7×	172 0.7×	184 0.9×	253 1.5×	108	2.1k
Xueying Li China	29	191 0.7×	314 1.1×	206 0.8×	124 0.6×	282 1.6×	165	2.5k
Fang Xue China	24	177 0.6×	599 2.2×	198 0.8×	123 0.6×	130 0.8×	104	1.7k

Countries citing papers authored by Abolfazl Avan

Since Specialization

Citations

This map shows the geographic impact of Abolfazl Avan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abolfazl Avan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abolfazl Avan more than expected).

Fields of papers citing papers by Abolfazl Avan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abolfazl Avan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abolfazl Avan. The network helps show where Abolfazl Avan may publish in the future.

Co-authorship network of co-authors of Abolfazl Avan

This figure shows the co-authorship network connecting the top 25 collaborators of Abolfazl Avan. A scholar is included among the top collaborators of Abolfazl Avan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abolfazl Avan. Abolfazl Avan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Avan, Abolfazl, et al.. (2025). The burden of stroke, ischaemic heart disease, and dementia in Africa, 1990–2021: an ecological analysis of the Global Burden of Disease 2021. The Lancet Global Health. 13(7). e1191–e1202.

John‐Baptiste, Ava, et al.. (2025). The impact of hypertension prevention and modification on dementia burden: A systematic review of economic studies. The Journal of Prevention of Alzheimer s Disease. 12(1). 100017–100017. 1 indexed citations

Avan, Abolfazl, et al.. (2025). An operational measurement of brain health: the ABCDS framework. The Lancet Neurology. 24(4). 291–292. 1 indexed citations

Seabrook, Jamie A., Abolfazl Avan, Colleen O’Connor, et al.. (2025). Dietary Patterns and Brain Health in Middle-Aged and Older Adults: A Narrative Review. Nutrients. 17(9). 1436–1436. 1 indexed citations

Avan, Abolfazl, Antonia Nucera, Saverio Stranges, et al.. (2024). Risk and sex-specific trends of dementia and stroke in Italy Compared to European and high-income countries and the world: global implications. Journal of Neurology. 271(5). 2745–2757. 2 indexed citations

Avan, Abolfazl, et al.. (2024). Inequalities in health-related quality of life and functional health of an aging population: A Canadian community perspective. PLoS ONE. 19(7). e0304457–e0304457.

Avan, Abolfazl, Anne Hege Aamodt, Geir Selbæk, et al.. (2023). Decreasing incidence of stroke, ischaemic heart disease and dementia in Norway, 1990–2019, a Global Burden of Disease study: an opportunity. European Journal of Neurology. 30(8). 2267–2277. 9 indexed citations

Asgharzadeh, Fereshteh, Atieh Yaghoubi, Mohammad Reza Eskandari, et al.. (2022). Angiotensin-converting enzyme inhibitor, Enalapril, inhibits tumor growth and potentiates the antitumor efficacy of 5-FU in colorectal cancer. SHILAP Revista de lepidopterología. 1 indexed citations

Hachinski, Vladimir & Abolfazl Avan. (2022). From Dementia to Eumentia: A New Approach to Dementia Prevention. Neuroepidemiology. 56(3). 151–156. 6 indexed citations

10.

Avan, Abolfazl & Vladimir Hachinski. (2022). Global, regional, and national trends of dementia incidence and risk factors, 1990–2019: A Global Burden of Disease study. Alzheimer s & Dementia. 19(4). 1281–1291. 54 indexed citations

11.

Morovatdar, Negar, Abolfazl Avan, Mahmoud Reza Azarpazhooh, et al.. (2021). Secular trends of ischaemic heart disease, stroke, and dementia in high-income countries from 1990 to 2017: the Global Burden of Disease Study 2017. Neurological Sciences. 43(1). 255–264. 22 indexed citations

12.

Hachinski, Vladimir, Abolfazl Avan, Jason Gilliland, & Shahram Oveisgharan. (2021). A new definition of brain health. The Lancet Neurology. 20(5). 335–336. 23 indexed citations

13.

Avan, Abolfazl & Vladimir Hachinski. (2021). Stroke and dementia, leading causes of neurological disability and death, potential for prevention (5108). Neurology. 96(15_supplement). 2 indexed citations

14.

Avan, Abolfazl, Amin Amiri, Naghmeh Mokhber, et al.. (2021). Association of lewy bodies, hippocampal sclerosis and amyloid angiopathy with dementia in community-dwelling elderly: A systematic review and meta-analysis. Journal of Clinical Neuroscience. 90. 124–131. 1 indexed citations

15.

Tabrizi, Reza, Afshin Borhani‐Haghighi, Kamran Bagheri Lankarani, et al.. (2020). Hookah Smoking: A Potentially Risk Factor for First-Ever Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 29(10). 105138–105138. 6 indexed citations

16.

Avan, Abolfazl, Hadi Digaleh, Mario Di Napoli, et al.. (2019). Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017. BMC Medicine. 17(1). 191–191. 322 indexed citations breakdown →

17.

Avan, Abolfazl, Mina Maftouh, Niccola Funel, et al.. (2014). MET As a Potential Target for the Treatment of Upper Gastrointestinal Cancers: Characterization of Novel c-Met Inhibitors from Bench to Bedside. Current Medicinal Chemistry. 21(8). 975–989. 17 indexed citations

18.

Avan, Abolfazl, Amir Avan, Tessa Y. S. Le Large, et al.. (2014). AKT1 and SELP Polymorphisms Predict the Risk of Developing Cachexia in Pancreatic Cancer Patients. PLoS ONE. 9(9). e108057–e108057. 36 indexed citations

19.

Avan, Abolfazl, Ali Shoeibi, Amir Azarpazhooh, et al.. (2014). Gaps and Hurdles Deter against Following Stroke Guidelines for Thrombolytic Therapy in Iran: Exploring the Problem. Journal of Stroke and Cerebrovascular Diseases. 24(2). 408–415. 11 indexed citations

20.

Maftouh, Mina, Abolfazl Avan, Rocco Sciarrillo, et al.. (2013). Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia. British Journal of Cancer. 110(1). 172–182. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact